Linda.Bunschoten

About Linda Bunschoten - Chief Marketing Officer

Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.
Feb 2024

Join Us at the SCOPE Summit 2024

By |2024-02-05T19:58:55+02:00February 2, 2024|Blog, News|Comments Off on Join Us at the SCOPE Summit 2024

Wondering how an integrated risk management solution incorporates education, process, and technology? Are you curious about how AI can enhance your daily tasks in clinical trials? If so, we invite you to join us at the SCOPE Summit 2024.

Dec 2023

20 Episodes of mindsON RBQM: Upskilling the Industry

By |2023-12-14T14:21:25+02:00December 14, 2023|Blog, News|Comments Off on 20 Episodes of mindsON RBQM: Upskilling the Industry

In this blog post, Keith Dorricott, our lead instructor at MyRBQM Academy, takes us on a reflective journey through the mindsON RBQM series. From its inception to its evolution and impact on over 1000 participants across 150 companies, Keith shares his insights and experiences.

Dec 2023

Decoding the ICH’s Q9(R1) Quality Risk Management Guideline

By |2023-12-11T11:44:27+02:00December 4, 2023|Blog, Free Infographics, News|Comments Off on Decoding the ICH’s Q9(R1) Quality Risk Management Guideline

Explore the impact of ICH's Q9(R1), Quality Risk Management, guideline on RBQM and clinical trials in our latest blog post. Don't miss our free infographic that simplifies this complex guideline. Enhance your risk strategies today!

Nov 2023

Advanced RBQM Solutions: Elevating the FSP Model in Clinical Trials

By |2023-12-01T13:46:08+02:00November 27, 2023|Blog, News|Comments Off on Advanced RBQM Solutions: Elevating the FSP Model in Clinical Trials

Our MyRBQM Functional Service Provision model redefines FSP models in clinical trials with its unique, independent RBQM solutions. It offers integrated risk management strategies, AI-augmented tools like the MyRBQM Portal, and specialized training through the MyRBQM Academy, setting new industry standards.

Nov 2023

Cyntegrity Hosts Virtual Dialogue on Responsible AI in Clinical Trials

By |2023-11-02T10:37:50+02:00November 2, 2023|News|Comments Off on Cyntegrity Hosts Virtual Dialogue on Responsible AI in Clinical Trials

We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.

Sep 2023

Pipeline Intelligence & M&A in the Modern Pharma Landscape

By |2023-09-05T14:37:50+02:00September 5, 2023|Blog, News|Comments Off on Pipeline Intelligence & M&A in the Modern Pharma Landscape

In a fast-changing pharma landscape, our MyRBQM® Portal transforms clinical trial and pipeline oversight and aids in M&A due diligence, offering a strategic edge in compliance and growth.

Jul 2023

Enhancing Clinical Trial Risk Management: A Response to the Growing Concerns over Fraudulent Studies

By |2023-07-20T12:20:47+02:00July 19, 2023|Blog, News|0 Comments

In this blog, we explore the growing concerns about fraudulent RCTs highlighted in a recent Nature article. Discover how innovative risk management approaches can detect, prevent, and tackle these issues, facilitating more robust regulatory oversight.

Jun 2023

Empowering Clinical Trials: MyRBQM Portal Debuts on Microsoft Azure Marketplace

By |2023-06-27T10:53:08+02:00June 27, 2023|News|0 Comments

MyRBQM Portal has made its debut on the Azure Marketplace. This milestone allows biopharmaceutical companies to streamline and unify their approach to risk management by using the secure and reliable Azure cloud platform.

Jun 2023

Boosting Oncology Care with Decentralized Clinical Trials

By |2023-06-06T15:11:23+02:00June 4, 2023|Blog, News|0 Comments

Discover how Decentralized Clinical Trials (DCTs) have the potential to reshape oncology care. Using our eyesON DCT Outlook, we reveal how patient demographics, broadband internet, and registered oncologists could drive DCT opportunities and potentially enhance cancer survivorship.

Go to Top